Q14766 (LTBP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Latent-transforming growth factor beta-binding protein 1 Short name=LTBP-1 Alternative name(s): Transforming growth factor beta-1-binding protein 1 Short name=TGF-beta1-BP-1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1721 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May be involved in the assembly, secretion and targeting of TGFB1 to sites at which it is stored and/or activated. May play critical roles in controlling and directing the activity of TGFB1. May have a structural role in the extra cellular matrix (ECM). |
| Subunit structure | The large latent complex of TGFB1 from platelets is composed of the TGFB1 molecule non-covalently associated with a disulfide-bonded complex of a dimer of the N-terminal propeptide of the TGFB1 precursor and LTBP1. LTBP1 does not bind directly to active TGFB1. Binds to FBN1 and FBN2. Interacts with ADAMTSL2. Ref.12 Ref.13 Ref.15 |
| Subcellular location | |
| Tissue specificity | Isoform Long is found in fibroblasts. |
| Domain | Associates covalently with small latent TGF-beta complex via domain TB 3. |
| Post-translational modification | Contains hydroxylated asparagine residues. Isoform Short N-terminus is blocked. The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains By similarity. Two intrachain disulfide bonds from the TB3 domain are rearranged upon TGFB1 binding, and form interchain bonds with TGFB1 propeptide, anchoring it to the extracellular matrix. |
| Sequence similarities | Belongs to the LTBP family. Contains 18 EGF-like domains. Contains 4 TB (TGF-beta binding) domains. |
| Sequence caution | The sequence BAD92038.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Secreted |
| Coding sequence diversity | Alternative splicing |
| Domain | EGF-like domain Repeat Signal |
| Ligand | Growth factor binding |
| PTM | Disulfide bond Glycoprotein Hydroxylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | sequestering of TGFbeta in extracellular matrix Traceable author statement Ref.15. Source: BHF-UCL |
| Cellular_component | proteinaceous extracellular matrix Non-traceable author statement Ref.7. Source: UniProtKB |
| Molecular_function | calcium ion binding Inferred from electronic annotation. Source: InterPro transforming growth factor beta-activated receptor activityNon-traceable author statement Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform Long (identifier: Q14766-1) Also known as: LTBP-1L; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Short (identifier: Q14766-2) Also known as: LTBP-1S; The sequence of this isoform differs from the canonical sequence as follows: 1-326: Missing. 327-345: EGSFPLRYVQDQVAAPFQL → MDTKLMCLLFFFSLPPLLV | ||||||
| Isoform 3 (identifier: Q14766-3) The sequence of this isoform differs from the canonical sequence as follows: 1-326: Missing. 327-345: EGSFPLRYVQDQVAAPFQL → MDTKLMCLLFFFSLPPLLV 724-776: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q14766-4) The sequence of this isoform differs from the canonical sequence as follows: 839-840: PV → PGI | ||||||
| Isoform 5 (identifier: Q14766-5) The sequence of this isoform differs from the canonical sequence as follows: 1-326: Missing. 327-345: EGSFPLRYVQDQVAAPFQL → MDTKLMCLLFFFSLPPLLV 839-840: PV → PGI | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | Potential | ||||||||||||||||||||||||
| Chain | 24 – 1721 | 1698 | Latent-transforming growth factor beta-binding protein 1 | PRO_0000007635 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Domain | 187 – 219 | 33 | EGF-like 1 | ||||||||||||||||||||||||
| Domain | 399 – 431 | 33 | EGF-like 2 | ||||||||||||||||||||||||
| Domain | 557 – 609 | 53 | TB 1 | ||||||||||||||||||||||||
| Domain | 626 – 663 | 38 | EGF-like 3; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 677 – 729 | 53 | TB 2 | ||||||||||||||||||||||||
| Domain | 873 – 910 | 38 | EGF-like 4; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 915 – 956 | 42 | EGF-like 5; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 957 – 997 | 41 | EGF-like 6; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 998 – 1037 | 40 | EGF-like 7; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1038 – 1078 | 41 | EGF-like 8; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1079 – 1119 | 41 | EGF-like 9; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1120 – 1160 | 41 | EGF-like 10; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1161 – 1201 | 41 | EGF-like 11; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1202 – 1243 | 42 | EGF-like 12; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1244 – 1281 | 38 | EGF-like 13; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1286 – 1328 | 43 | EGF-like 14; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1347 – 1401 | 55 | TB 3 | ||||||||||||||||||||||||
| Domain | 1424 – 1466 | 43 | EGF-like 15; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1467 – 1503 | 37 | EGF-like 16; calcium-binding Potential | ||||||||||||||||||||||||
| Domain | 1524 – 1577 | 54 | TB 4 | ||||||||||||||||||||||||
| Domain | 1621 – 1657 | 37 | EGF-like 17 | ||||||||||||||||||||||||
| Domain | 1662 – 1706 | 45 | EGF-like 18; calcium-binding Potential | ||||||||||||||||||||||||
| Motif | 1174 – 1176 | 3 | Cell attachment site Potential | ||||||||||||||||||||||||
| Compositional bias | 100 – 130 | 31 | Pro-rich | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Modified residue | 974 | 1 | (3R)-3-hydroxyasparagine | ||||||||||||||||||||||||
| Modified residue | 1137 | 1 | (3R)-3-hydroxyasparagine | ||||||||||||||||||||||||
| Modified residue | 1597 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||
| Glycosylation | 347 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 378 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 424 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 620 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1197 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1250 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 1366 | 1 | N-linked (GlcNAc...) Ref.11 | CAR_000184 | |||||||||||||||||||||||
| Disulfide bond | 191 ↔ 201 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 195 ↔ 207 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 209 ↔ 218 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 403 ↔ 413 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 407 ↔ 419 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 421 ↔ 430 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 630 ↔ 641 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 636 ↔ 650 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 652 ↔ 665 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 877 ↔ 889 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 884 ↔ 898 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 900 ↔ 913 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 919 ↔ 931 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 926 ↔ 940 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 942 ↔ 955 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 961 ↔ 972 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 967 ↔ 981 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 984 ↔ 996 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1002 ↔ 1013 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1008 ↔ 1022 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1025 ↔ 1036 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1042 ↔ 1053 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1048 ↔ 1062 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1064 ↔ 1077 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1083 ↔ 1094 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1089 ↔ 1103 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1105 ↔ 1118 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1124 ↔ 1135 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1130 ↔ 1144 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1146 ↔ 1159 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1165 ↔ 1177 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1172 ↔ 1186 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1188 ↔ 1200 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1206 ↔ 1218 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1212 ↔ 1227 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1229 ↔ 1242 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1248 ↔ 1260 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1254 ↔ 1269 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1349 ↔ 1372 | Ref.16 | |||||||||||||||||||||||||
| Disulfide bond | 1359 ↔ 1384 | Alternate Ref.16 | |||||||||||||||||||||||||
| Disulfide bond | 1359 | Interchain (with C-33 in TGFB1); alternate By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1373 ↔ 1389 | Ref.16 | |||||||||||||||||||||||||
| Disulfide bond | 1374 ↔ 1401 | Ref.16 | |||||||||||||||||||||||||
| Disulfide bond | 1384 | Interchain (with C-33 in TGFB1); alternate By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1471 ↔ 1482 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1477 ↔ 1491 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1625 ↔ 1636 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1631 ↔ 1645 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1666 ↔ 1681 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1676 ↔ 1690 | By similarity | |||||||||||||||||||||||||
| Disulfide bond | 1692 ↔ 1705 | By similarity | |||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 1 – 326 | 326 | Missing in isoform Short, isoform 3 and isoform 5. | VSP_036963 | |||||||||||||||||||||||
| Alternative sequence | 327 – 345 | 19 | EGSFP…APFQL → MDTKLMCLLFFFSLPPLLV in isoform Short, isoform 3 and isoform 5. | VSP_036964 | |||||||||||||||||||||||
| Alternative sequence | 724 – 776 | 53 | Missing in isoform 3. | VSP_036965 | |||||||||||||||||||||||
| Alternative sequence | 839 – 840 | 2 | PV → PGI in isoform 4 and isoform 5. | VSP_040125 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||
| Mutagenesis | 1385 – 1388 | 4 | EIFP → DL: Loss of binding to TGFB1. Ref.12 | ||||||||||||||||||||||||
| Sequence conflict | 50 | 1 | R → AS in AAA96327. Ref.7 | ||||||||||||||||||||||||
| Sequence conflict | 691 | 1 | H → Y in AAA61160. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 694 | 1 | S → P in BP291349. Ref.8 | ||||||||||||||||||||||||
| Sequence conflict | 710 | 1 | Missing in AAA61160. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 710 | 1 | Missing in AAM03124. Ref.2 | ||||||||||||||||||||||||
| Sequence conflict | 744 | 1 | R → M in BP291349. Ref.8 | ||||||||||||||||||||||||
| Sequence conflict | 792 – 794 | 3 | PGV → ARS in AAA61160. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 792 – 794 | 3 | PGV → ARS in AAM03124. Ref.2 | ||||||||||||||||||||||||
| Sequence conflict | 831 | 1 | T → A in AAA61160. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 1378 | 1 | V → A in AAA61160. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 1378 | 1 | V → A in AAM03124. Ref.2 | ||||||||||||||||||||||||
| Sequence conflict | 1378 | 1 | V → A in BAD92038. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 1378 | 1 | V → A in EAX00437. Ref.5 | ||||||||||||||||||||||||
| Sequence conflict | 1378 | 1 | V → A in AAI30290. Ref.6 | ||||||||||||||||||||||||
| Sequence conflict | 1648 | 1 | F → L in AAA61160. Ref.1 | ||||||||||||||||||||||||
| Sequence conflict | 1648 | 1 | F → L in AAM03124. Ref.2 | ||||||||||||||||||||||||
| Sequence conflict | 1661 | 1 | V → F in AAA61160. Ref.1 | ||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Beta strand | 1340 – 1342 | 3 | |||||||||||||||||||||||||
| Beta strand | 1346 – 1353 | 8 | |||||||||||||||||||||||||
| Turn | 1355 – 1358 | 4 | |||||||||||||||||||||||||
| Beta strand | 1366 – 1368 | 3 | |||||||||||||||||||||||||
| Helix | 1369 – 1374 | 6 | |||||||||||||||||||||||||
| Beta strand | 1378 – 1382 | 5 | |||||||||||||||||||||||||
| Beta strand | 1385 – 1388 | 4 | |||||||||||||||||||||||||
| Beta strand | 1392 – 1394 | 3 | |||||||||||||||||||||||||
| Helix | 1395 – 1400 | 6 | |||||||||||||||||||||||||
| Beta strand | 1408 – 1410 | 3 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences." Kanzaki T., Olofsson A., Moren A., Wernstedt C., Hellman U., Miyazono K., Claesson-Welsh L., Heldin C.-H. Cell 61:1051-1061(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), PARTIAL PROTEIN SEQUENCE. Tissue: Fibroblast and Platelet. |
| [2] | "Major alternative spliced-form of LTBP1 mRNA in human glomerular endothelial cell." Kwak J.H., Shin K.Y., Kim S.I. Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT). |
| [3] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Brain. |
| [4] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT). Tissue: Brain. |
| [7] | "Efficient association of an amino-terminally extended form of human latent transforming growth factor-beta binding protein with the extracellular matrix." Olofsson A., Ichijo H., Moren A., ten Dijke P., Miyazono K., Heldin C.-H. J. Biol. Chem. 270:31294-31297(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-346. Tissue: Blood. |
| [8] | Suzuki Y., Yamashita R., Shirota M., Sakakibara Y., Chiba J., Nakai K., Sugano S. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 684-875 (ISOFORMS 4 AND 5). |
| [9] | "Latent transforming growth factor-beta binding proteins (LTBPs) --structural extracellular matrix proteins for targeting TGF-beta action." Saharinen J., Hyytiainen M., Taipale J., Keski-Oja J. Cytokine Growth Factor Rev. 10:99-117(1999) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [10] | "The latent transforming growth factor beta binding protein (LTBP) family." Oklu R., Hesketh R. Biochem. J. 352:601-610(2000) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [11] | "Hybrid and complex glycans are linked to the conserved N-glycosylation site of the third eight-cysteine domain of LTBP-1 in insect cells." Rudd P.M., Downing A.K., Cadene M., Harvey D.J., Wormald M.R., Weir I., Dwek R.A., Rifkin D.B., Gleizes P.E. Biochemistry 39:1596-1603(2000) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT ASN-1366. |
| [12] | "Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta." Saharinen J., Keski-Oja J. Mol. Biol. Cell 11:2691-2704(2000) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TGFB1, MUTAGENESIS OF 1385-GLU--PRO-1388. |
| [13] | "Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein." Isogai Z., Ono R.N., Ushiro S., Keene D.R., Chen Y., Mazzieri R., Charbonneau N.L., Reinhardt D.P., Rifkin D.B., Sakai L.Y. J. Biol. Chem. 278:2750-2757(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FBN1. |
| [14] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1597, MASS SPECTROMETRY. Tissue: Platelet. |
| [15] | "ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation." Le Goff C., Morice-Picard F., Dagoneau N., Wang L.W., Perrot C., Crow Y.J., Bauer F., Flori E., Prost-Squarcioni C., Krakow D., Ge G., Greenspan D.S., Bonnet D., Le Merrer M., Munnich A., Apte S.S., Cormier-Daire V. Nat. Genet. 40:1119-1123(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ADAMTSL2. |
| [16] | "Solution structure of the third TB domain from LTBP1 provides insight into assembly of the large latent complex that sequesters latent TGF-beta." Lack J., O'Leary J.M., Knott V., Yuan X., Rifkin D.B., Handford P.A., Downing A.K. J. Mol. Biol. 334:281-291(2003) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1340-1412, DISULFIDE BONDS. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M34057 mRNA. Translation: AAA61160.1. AF489528 mRNA. Translation: AAM03124.1. AB208801 mRNA. Translation: BAD92038.1. Different initiation. AC019195 Genomic DNA. Translation: AAY14953.1. AC019127 Genomic DNA. Translation: AAY24260.1. AC020594 Genomic DNA. Translation: AAY15036.1. CH471053 Genomic DNA. Translation: EAX00437.1. BC130289 mRNA. Translation: AAI30290.1. L48925 Genomic DNA. Translation: AAA96327.1. BP291349 mRNA. No translation available. | ||||||||||||
| IPI | IPI00302679. IPI00784258. IPI00894247. IPI00973086. IPI00973177. | ||||||||||||
| PIR | A35626. | ||||||||||||
| RefSeq | NP_000618.3. NM_000627.3. NP_001159736.1. NM_001166264.1. NP_001159737.1. NM_001166265.1. NP_001159738.1. NM_001166266.1. NP_996826.2. NM_206943.2. | ||||||||||||
| UniGene | Hs.619315. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q14766. | ||||||||||||
| SMR | Q14766. Positions 550-739, 872-1506. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-50011N. | ||||||||||||
| IntAct | Q14766. 1 interaction. | ||||||||||||
| MINT | MINT-1522113. | ||||||||||||
| STRING | 9606.ENSP00000346467. | ||||||||||||
PTM databases | |||||||||||||
| GlycoSuiteDB | P22064. | ||||||||||||
| PhosphoSite | Q14766. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q14766. | ||||||||||||
| PRIDE | Q14766. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000354476; ENSP00000346467; ENSG00000049323. ENST00000390003; ENSP00000374653; ENSG00000049323. ENST00000404525; ENSP00000385359; ENSG00000049323. ENST00000404816; ENSP00000386043; ENSG00000049323. ENST00000407925; ENSP00000384091; ENSG00000049323. | ||||||||||||
| GeneID | 4052. | ||||||||||||
| KEGG | hsa:4052. | ||||||||||||
| UCSC | uc002rou.3. human. uc002rov.3. human. uc021vft.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 4052. | ||||||||||||
| GeneCards | GC02P033172. | ||||||||||||
| HGNC | HGNC:6714. LTBP1. | ||||||||||||
| HPA | CAB025428. HPA006221. | ||||||||||||
| MIM | 150390. gene. | ||||||||||||
| neXtProt | NX_Q14766. | ||||||||||||
| PharmGKB | PA30477. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG318792. | ||||||||||||
| KO | K08023. | ||||||||||||
| OMA | TQLGRCF. | ||||||||||||
| OrthoDB | EOG4C87RH. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_118779. Extracellular matrix organization. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q14766. | ||||||||||||
| Bgee | Q14766. | ||||||||||||
| CleanEx | HS_LTBP1. | ||||||||||||
| Genevestigator | Q14766. | ||||||||||||
| GermOnline | ENSG00000049323. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 3.90.290.10. 5 hits. | ||||||||||||
| InterPro | IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR017878. TB_dom. [Graphical view] | ||||||||||||
| Pfam | PF07645. EGF_CA. 12 hits. PF00683. TB. 4 hits. [Graphical view] | ||||||||||||
| SMART | SM00181. EGF. 5 hits. SM00179. EGF_CA. 13 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF57581. Fibril-assoc. 4 hits. | ||||||||||||
| PROSITE | PS00010. ASX_HYDROXYL. 13 hits. PS00022. EGF_1. 2 hits. PS01186. EGF_2. 11 hits. PS50026. EGF_3. 14 hits. PS01187. EGF_CA. 15 hits. PS51364. TB. 4 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | LTBP1. human. | ||||||||||||
| EvolutionaryTrace | Q14766. | ||||||||||||
| GenomeRNAi | 4052. | ||||||||||||
| NextBio | 15874. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | LTBP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q14766 Secondary accession number(s): A1L3V1 Q8TD95 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
